News About: Pharm. Industry
Kim Yeon-pan named KPMA vice-president
Kim Yeon-pan, incumbent vice chairman of Hanmi Pharmaceutical, has been named the new vice-president of the Korea Pharmaceutical Manufacturers Association.
A graduate of Youngnam pharmacy school, Kim has served at ...
Domestic, multinational clinical studies top 439 last year
The number of Korean and multinational clinical trials approved last year was 439, up 10 percent compare with 400 in 2009.
The nation's drug watchdog said it approved 210 trials for multinational drug makers last y...
Pharmaceutical CEOs urged to activate communication within organization
Chief Executive Officers (CEO) in pharmaceutical sector will have to drop formalities and activate internal communication to develop better policies for salespersons, experts claim.
“If there is no communication be...
Kukje veers into health food market
Kukje Pharmaceutical Co. is set to enter the domestic health food market to create new income sources.
To this end, the company signed an agreement with Canada based Natural Factors Nutritional Products Ltd. to dis...
Almetec to be exposed to fiercer competition
Daiichi-Sankyo’s Almetec (olmesartan medoxomi), a selective AT1 subtype angiotensin II receptor antagonist, will not be stable in 2014, as a growing number of Korean pharmaceutical companies are poised to enter a 90 b...
Small- and medium-sized pharmaceutical companies in survival crisis
For decades, the Korea Pharmaceutical Industry Cooperative (KPIC) was a solid advocate of the country’s small- and medium sized pharmaceutical firms.
While it is trying to raise its voice to make its public sentime...
Boryung eying sales of 100 billion won with new antihypertensive agent
Boryung Pharmaceutical Co., one of Korea's largest pharmaceutical companies, says it will launch its homegrown antihypertensive drug, Fimasartan, in March as its health insurance price is expected to be settled sooner...
Conspicuous sales rise for Celebrex
Pfizer's Celebrex gained a majority of sales for new-generation painkillers last year amid growing safety concerns over popular Gevorin and other acetaminophen drugs, according to Ubist market data.
Last year, sale...
Pharmaceutical firms mull smart work
Pharmaceutical companies are considering making a big push for “smart work,” while closing their branch offices - working away from the traditional office using the latest information technology products
The push f...
New homegrown antimalarial drug to be approved in first half
The Korea Food and Drug Administration is likely to approve Pyramax, an investigational antimalarial medicine developed by Shinpoong Pharmaceutical Co, possibly in the first half of this year.
Pyramax is a fixed-do...
